Literature DB >> 22814785

Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective.

Mitchell W Krucoff1, Ralph G Brindis, Patricia K Hodgson, Michael J Mack, David R Holmes.   

Abstract

Barriers to medical device innovation compromise timelines and costs from bench to bedside. Fragmented strategies by individual competitors are no longer sustainable. Pragmatically focused pre-competitive collaboration across stakeholders approaches innovation as an ecosystem. Desiloing experience and expertise encourages high-impact infrastructure efficiencies unique to pre-competitive constructs. Alignment of processes and objectives across the regulatory, reimbursement, clinical research, and clinical practice enterprises, with particular attention to the total product life cycle and continuous accrual of safety information, promotes more predictable equipoise for speed of access relative to residual safety concerns. Professional societies are well positioned to convene pre-competitive dialogue, facilitate alignment, and add perspective to equipoise within the innovation ecosystem.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2012        PMID: 22814785     DOI: 10.1016/j.jcin.2012.03.023

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  10 in total

Review 1.  Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).

Authors:  Emily P Zeitler; Sana M Al-Khatib; Joseph P Drozda; Larry G Kessler; Ajay J Kirtane; David F Kong; John Laschinger; Danica Marinac-Dabic; Marie-Claude Morice; Terrie Reed; Art Sedrakyan; Kenneth M Stein; James Tcheng; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2015-07-30       Impact factor: 4.749

2.  Multiregional medical device development: regulatory perspective.

Authors:  Atsushi Tamura; Hiromu Kutsumi
Journal:  Clin J Gastroenterol       Date:  2014-04-03

Review 3.  Overview of the US FDA medical device approval process.

Authors:  Ashwani Sastry
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

Review 4.  Overview of High-Risk Medical Device Innovation in Gastroenterology from 2000 to 2014: Enhancing the Pipeline.

Authors:  Nasir Saleem; Shuai Xu
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

5.  Proceedings from Heart Rhythm Society's emerging technologies forum, Boston, MA, May 12, 2015.

Authors:  Emily P Zeitler; Sana M Al-Khatib; David Slotwiner; Uday N Kumar; Paul Varosy; David R Van Wagoner; Gregory M Marcus; Fred M Kusumoto; Laura Blum
Journal:  Heart Rhythm       Date:  2016-02       Impact factor: 6.343

6.  Medical Device Product Innovation Choices in Asia: An Empirical Analysis Based on Product Space.

Authors:  Feng Hu; Liping Qiu; Haiyan Zhou
Journal:  Front Public Health       Date:  2022-04-13

7.  Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation.

Authors:  Aaron S Kesselheim; Shuai Xu; Jerry Avorn
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

Review 8.  Barriers to medical device innovation.

Authors:  Jacob Bergsland; Ole Jakob Elle; Erik Fosse
Journal:  Med Devices (Auckl)       Date:  2014-06-13

9.  Application of quality by design for 3D printed bone prostheses and scaffolds.

Authors:  Daniel Martinez-Marquez; Ali Mirnajafizadeh; Christopher P Carty; Rodney A Stewart
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

10.  Teaching Targeted Drug Discovery and Development to Healthcare Professionals.

Authors:  Renee Fruchter; Meleha Ahmad; Michael Pillinger; Claudia Galeano; Bruce N Cronstein; Gabrielle Gold-von Simson
Journal:  Clin Transl Sci       Date:  2017-11-28       Impact factor: 4.689

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.